Meihua Medical Technologies (MHUA): Company Short-Term Debts

Public company logo of Meihua Medical (MHUA)

MeihuaMed (MHUA) is actively expanding into BRICS and Latin American markets to offset the pressure of Western sanctions. The organization's short-term debt reflects these shifts, with the current level sitting around 0.00. While the business leverages low-cost Chinese manufacturing and export certificates, trade wars with the US and regional instability pose significant liquidity risks for the issuer.

MHUA (MeihuaMed) Company Short-Term Debts history from 04/28/2023 to 12/20/2025

Analytical breakdowns for Meihua Medical Technologies (MHUA)

- stock price and consensus target price:
Stock Price Meihua Medical|MHUA - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Meihua Medical Technologies Co., Ltd.|MHUA - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share MeihuaMed|MHUA - Book Capitalization|Market Value to Book Value Ratio meihuamed.com|MHUA - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio MeihuaMed|MHUA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Meihua Medical|MHUA - Company Total Debt Obligations|Debt to Book Capitalization Ratio Meihua Medical Technologies Co., Ltd.|MHUA - Company Long-Term Indebtedness|Company Short-Term Debt MeihuaMed|Quick Liquidity Indicator meihuamed.com
- net income and valuation multiples indicators:
MHUA - Profit After Payment of Taxes
Fundamental company analysis:MHUA - meihuamed.com
Flagship merchandise of Meihua Medical Technologies

This indicator measures liquidity sensitivity to current liabilities, identifying the operating cycle's dependence on external financing and the risk of working capital deficits. The trend in short-term loan volumes allows for an assessment of whether MeihuaMed (MHUA) adaptation to foreign regulators and the scaling of product output are accompanied by systemic debt pressure or temporary technical refinancing.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings CERS|TKNO: Company Current Liabilities|MGRM - Company Short-Term Debts|sharpstechnology.com (STSS) - Company Short-Term Debt|Company Current Liabilities InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Company Short-Term Debts|Short-Term Debt KORU Medical Systems Inc. KRMD|Company Short-Term Debt Nyxoah, S.A. (NYXH)|Microbot Medical, Inc - Company Short-Term Indebtedness|Pro-Dex, Inc. - Company Current Liabilities|Amount of Current Liabilities ZTEK (zentek.com)|ELUT - Company Short-Term Debt|Short-Term Debt Volume Milestone Scientific Inc MLSS|NEXGEL, Inc (NXGL) - Company Short-Term Debt|Company Current Liabilities Retractable Technologies, Inc.|HBIO (Harvard Bioscience) - Company Short-Term Debts|Short-Term Debt femasys.com FEMY|Company Short-Term Debts POAI|Short-Term Debt Volume callanjmb.com|Company Short-Term Debts ATRI (Atrion Corp)|Company Short-Term Loans and Borrowings NURO